Evidence map›Paper›PMID 22379084›Full record

ArticleJournal of virology2012

A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.

Antonio J Acosta-Hoyos, Suzanne E Matsuura, Peter R Meyer, Walter A Scott

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antonio J Acosta-HoyosDepartment of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Suzanne E Matsuura
Peter R Meyer
Walter A Scott
University of Miami · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
Biochemical Mechanisms of Drug Resistance in HIV RTR01AI039973 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZHANG, YANBIN · 1997 to 2012
$4.5M
NIAID NIH HHS 5P30-AI-073961NIAID NIH HHS AI-39973NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI039973
6 · The paper itself

Abstract

Resistance to nucleoside reverse transcriptase (RT) inhibitors is conferred on human immunodeficiency virus type 1 through thymidine analogue resistance mutations (TAMs) that increase the ability of RT to excise chain-terminating nucleotides after they have been incorporated. The RT mutation M184V is a potent suppressor of TAMs. In RT containing TAMs, the addition of M184V suppressed the excision of 3'-deoxy-3'-azidothymidine monophosphate (AZTMP) to a greater extent on an RNA template than on a DNA template with the same sequence. The catalytically inactive RNase H mutation E478Q abolished this difference. The reduction in excision activity was similar with either ATP or pyrophosphate as the acceptor substrate. Decreased excision of AZTMP was associated with increased cleavage of the RNA template at position -7 relative to the primer terminus, which led to increased primer-template dissociation. Whether M184V was present or not, RT did not initially bind at the -7 cleavage site. Cleavage at the initial site was followed by RT dissociation and rebinding at the -7 cleavage site, and the dissociation and rebinding were enhanced when the M184V mutation was present. In contrast to the effect of M184V, the K65R mutation suppressed the excision activity of RT to the same extent on either an RNA or a DNA template and did not alter the RNase H cleavage pattern. Based on these results, we propose that enhanced RNase H cleavage near the primer terminus plays a role in M184V suppression of AZT resistance, while K65R suppression occurs through a different mechanism.

Indexed as

MutationAdenosine TriphosphateDideoxynucleotidesDNA PrimersDrug Resistance, ViralHIV-1HIV Reverse TranscriptaseHumansNucleotidesRibonuclease HRNA, ViralThymine NucleotidesZidovudine3'-azido-3'-deoxythymidine 5'phosphateAdenosine TriphosphateDideoxynucleotidesDNA PrimersHIV Reverse TranscriptaseNucleotidesreverse transcriptase, Human immunodeficiency virus 1Ribonuclease HRNA, ViralThymine NucleotidesZidovudine

Identifiers

PMID22379084
PMCPMC3347382
OpenAlexW2111766508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.